![]() |
![]() |
COVID-19 Funding Opportunities The Office of the Vice Provost for Research (VPR) has compiled a list of funding opportunities specific to COVID-19. This list will be updated as new opportunities arise. Internal Deadline: 7/20/21 The Searle Scholars Program supports the independent
research of 15 outstanding early-career scientists each year who have
recently been appointed as assistant professors on a tenure-track appointment.
The program is primarily interested in the potential of applicants to
make innovative and high-impact contributions to research over an extended
period of time. Applicants are expected to be pursuing
independent research careers in biochemistry, cell biology, genetics,
immunology, neuroscience, pharmacology, and related areas in chemistry,
medicine, and the biological sciences. The Searle Scholars Program does
not ordinarily support purely clinical research but has supported research
programs that include both clinical and basic components. Eligibility &
Requirements:
Internal Nomination Process: Interested applicants should complete their application
at the following link: https://jhu.infoready4.com/#competitionDetail/1845598 Requirements are listed below. 1. Brief proposal, including the following sections:
2. Investigator CV, including current external research support and publications. 3. List of proposed reference letter writers (see
opportunity for specific guidance). Questions? Comments? Email the Office of
Foundation Relations at FoundationRelations@jhu.edu.
No application deadline The Michael J. Fox Foundation is sponsoring a $2 million prize to the first team to develop a viable selective alpha-synuclein PET tracer and agree to make that tracer available broadly. The ability to image alpha-synuclein deposition
in the brain would be a game-changing achievement for the Parkinson's
disease (PD) field. The accumulation of aggregated alpha-synuclein is
a pathological hallmark of PD and a priority target for drug development
given its hypothesized contribution to neurodegeneration. In vivo imaging
of alpha-synuclein pathology could be useful as a biomarker of the presence
of disease and disease progression and as a pharmacodynamic tool for
drug development. With this prize, the Foundation seeks to attract research
teams and accelerate momentum to speed the development of such a tracer. Contestants: Anyone is eligible for
the prize who agrees to all contest rules. Contestants may be MJFF funded
or not and can be from either academia or industry. Contest rules:
Criteria for winning: The winning contestant
must demonstrate that the radiotracer binds with relatively high selectivity
to alpha-synuclein according to pre-specified criteria and must demonstrate
proof-of-concept in human subjects, including people with Parkinson's
disease and/or another synucleinopathy. See below for more details on
submission requirements. Timeline: There is no deadline
for submissions. The $2 million award will be issued to the first
contestant who submits compelling evidence of a viable selective tracer
and agrees to its widespread use. If no award is given by mid-2018,
The Michael J. Fox Foundation will evaluate the state of the field and
utility of such a prize. |
![]() |
|
||||||
|
|
|
JHM Appointments | Employment @ JHM | Finding a Doctor | Disclaimer | Maps & Directions | Contact JHM |
|